Figure 3 shows that the number of cells with the phenotype Axl+SOX2+, EGF+SOX2+, and CD87+SOX2+ is significantly higher in patients with SCLC than in healthy volunteers (Figure 3). This evidence concerns the gene AXL and small cell lung carcinoma.